High tumor grade correlated with higher frequencies of CD3+, CD68+ CD163+ TAMs, and CD25+ FOXP3+ Treg cells, but Treg frequencies were significant predictors of favorable prognosis in patients with familial ovarian cancer (11/73 patients with BRCA mutation) [140]. This evidence concerns the gene FOXP3 and neoplasm.